Varian Medical Systems, Inc. (VAR) Updates Q4 Earnings Guidance

Paterniano Del Favero
Agosto 6, 2017

CrestPoint Capital Management LLC's holdings in Varian Medical Systems were worth $712,000 at the end of the most recent reporting period. Thrivent Financial for Lutherans raised its stake in shares of Varian Medical Systems by 6.2% in the fourth quarter. First Eagle Investment Management LLC now owns 4,679,471 shares of the medical equipment provider's stock worth $482,875,000 after buying an additional 38,005 shares during the period. Finally, First Eagle Investment Management LLC increased its position in shares of Varian Medical Systems by 7.5% in the first quarter. Thrivent Financial for Lutherans now owns 3,240 shares of the medical equipment provider's stock worth $291,000 after buying an additional 190 shares during the last quarter. Heritage Trust Co acquired a new position in shares of Varian Medical Systems during the first quarter valued at approximately $118,000. Royal Bank Of Canada increased their target price on shares of Varian Medical Systems from $82.00 to $90.00 and gave the stock a "sector perform" rating in a report on Thursday, April 27th. Teachers Advisors LLC now owns 107,778 shares of the medical equipment provider's stock worth $9,676,000 after buying an additional 4,000 shares during the period. Finally, Pacer Advisors Inc. raised its stake in shares of Varian Medical Systems by 3.1% in the first quarter. The fund owned 11,750 shares of the medical equipment provider's stock after selling 19,025 shares during the period.

Varian Medical Systems, Inc. has a one year low of $75.20 and a one year high of $107.08. (NYSE:VAR) traded down 0.55% on Friday, hitting $96.61. 920,790 shares of the company's stock traded hands. Shares are trading at $96.67 a tad under $103.21, the 50 day moving average and marginally over the 200 day moving average of $92.66.

WARNING: "Varian Medical Systems, Inc".

Varian Medical Systems, Inc.'s P/E ratio is 31.78 and the market cap is 8.85B.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $1.04 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.95 by $0.09. The business had revenue of $662.40 million for the quarter, compared to analyst estimates of $663.86 million. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The company's revenue for the quarter was up 3.0% compared to the same quarter previous year. In the latest earnings report the EPS was $3.04 and is expected to be $3.94 for the current year with 91,699,000 shares presently outstanding. Varian Medical Systems's revenue for the quarter was up 3.0% on a year-over-year basis. (VAR) Shares Sold by Smithbridge Asset Management Inc. DE cut its position in Varian Medical Systems, Inc. "DE" was first reported by Transcript Daily and is the property of of Transcript Daily. If you are reading this article on another domain, it was illegally copied and reposted in violation of USA & worldwide trademark & copyright legislation. The original version of this piece can be read at https://transcriptdaily.com/2017/08/04/varian-medical-systems-inc-var-shares-sold-by-smithbridge-asset-management-inc-de-updated-updated.html. Jefferies Group LLC reiterated a "buy" rating on shares of Varian Medical Systems in a research note on Thursday, May 11th. Off Wall Street started coverage on shares of Varian Medical Systems in a report on Monday, April 24th. Goldman Sachs Group, Inc. Citigroup Inc. raised Varian Medical Systems from a "neutral" rating to a "buy" rating in a report on Monday, May 15th.

July 28 investment analysts at Jefferies maintained a company rating of "Neutral" but moved up the price target from $85.00 to $88.00.

Several research analysts have recently commented on the stock. Varian Medical Systems presently has an average rating of "Hold" and an average price target of $96.28. Also, EVP Kolleen T. Kennedy sold 56,573 shares of Varian Medical Systems stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $99.76, for a total transaction of $5,643,722.48. Following the completion of the sale, the director now owns 2,161 shares of the company's stock, valued at $223,058.42. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP John W. Kuo sold 734 shares of the firm's stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $99.67, for a total value of $1,975,359.73. Following the sale, the executive vice president now directly owns 27,688 shares of the company's stock, valued at approximately $2,893,119.12. The disclosure for this sale can be found here. In the last three months, insiders have sold 144,087 shares of company stock valued at $14,652,328.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock.

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE